202 related articles for article (PubMed ID: 11454935)
1. Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.
Irie M; Terada T; Sawada K; Saito H; Inui K
J Pharmacol Exp Ther; 2001 Aug; 298(2):711-7. PubMed ID: 11454935
[TBL] [Abstract][Full Text] [Related]
2. Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2.
Terada T; Sawada K; Saito H; Hashimoto Y; Inui K
Am J Physiol; 1999 Jun; 276(6):G1435-41. PubMed ID: 10362647
[TBL] [Abstract][Full Text] [Related]
3. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
Ganapathy ME; Huang W; Wang H; Ganapathy V; Leibach FH
Biochem Biophys Res Commun; 1998 May; 246(2):470-5. PubMed ID: 9610386
[TBL] [Abstract][Full Text] [Related]
4. Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.
Sawada K; Terada T; Saito H; Hashimoto Y; Inui KI
J Pharmacol Exp Ther; 1999 Nov; 291(2):705-9. PubMed ID: 10525090
[TBL] [Abstract][Full Text] [Related]
5. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.
Friedrichsen GM; Chen W; Begtrup M; Lee CP; Smith PL; Borchardt RT
Eur J Pharm Sci; 2002 Jul; 16(1-2):1-13. PubMed ID: 12113886
[TBL] [Abstract][Full Text] [Related]
7. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications.
Döring F; Walter J; Will J; Föcking M; Boll M; Amasheh S; Clauss W; Daniel H
J Clin Invest; 1998 Jun; 101(12):2761-7. PubMed ID: 9637710
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.
Terada T; Sawada K; Irie M; Saito H; Hashimoto Y; Inui K
Pflugers Arch; 2000 Sep; 440(5):679-84. PubMed ID: 11007306
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
10. Transport of the photodynamic therapy agent 5-aminolevulinic acid by distinct H+-coupled nutrient carriers coexpressed in the small intestine.
Anderson CM; Jevons M; Thangaraju M; Edwards N; Conlon NJ; Woods S; Ganapathy V; Thwaites DT
J Pharmacol Exp Ther; 2010 Jan; 332(1):220-8. PubMed ID: 19789362
[TBL] [Abstract][Full Text] [Related]
11. The apical uptake transporter of levofloxacin is distinct from the peptide transporter in human intestinal epithelial Caco-2 cells.
Fukumori S; Murata T; Takaai M; Tahara K; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2008; 23(5):373-8. PubMed ID: 18974615
[TBL] [Abstract][Full Text] [Related]
12. Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice.
Yang B; Smith DE
Drug Metab Dispos; 2013 Mar; 41(3):608-14. PubMed ID: 23264448
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
14. Transport of the phosphonodipeptide alafosfalin by the H+/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells.
Neumann J; Bruch M; Gebauer S; Brandsch M
Eur J Biochem; 2004 May; 271(10):2012-7. PubMed ID: 15128310
[TBL] [Abstract][Full Text] [Related]
15. Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1.
Groneberg DA; Döring F; Eynott PR; Fischer A; Daniel H
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G697-704. PubMed ID: 11518682
[TBL] [Abstract][Full Text] [Related]
16. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
17. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
[TBL] [Abstract][Full Text] [Related]
18. Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein.
Sun D; Landowski CP; Chu X; Wallsten R; Komorowski TE; Fleisher D; Amidon GL
AAPS PharmSci; 2001; 3(1):E2. PubMed ID: 11741253
[TBL] [Abstract][Full Text] [Related]
19. Delineation of human peptide transporter 1 (hPepT1)-mediated uptake and transport of substrates with varying transporter affinities utilizing stably transfected hPepT1/Madin-Darby canine kidney clones and Caco-2 cells.
Bhardwaj RK; Herrera-Ruiz D; Sinko PJ; Gudmundsson OS; Knipp G
J Pharmacol Exp Ther; 2005 Sep; 314(3):1093-100. PubMed ID: 15901802
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of zinc on PEPT1-mediated transport of glycylsarcosine and beta-lactam antibiotics in human intestinal cell line Caco-2.
Okamura M; Terada T; Katsura T; Saito H; Inui K
Pharm Res; 2003 Sep; 20(9):1389-93. PubMed ID: 14567632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
